ACRS Historical PE Ratio image   This ACRS PE ratio history page last updated 11/10/2022
ACRS PE History Chart
PeriodPriceGAAPTTMPE
Q3 2022
11/8/2022
16.21-0.30-1.29NA
Q2 2022
8/3/2022
14.40-0.31-1.34NA
Q1 2022
5/10/2022
11.12-0.31-1.37NA
Q4 2021
2/24/2022
14.12-0.37-1.63NA
Q3 2021
11/2/2021
16.48-0.35-1.56NA
Q2 2021
8/5/2021
14.76-0.34-1.46NA
Q1 2021
5/7/2021
22.95-0.57-1.40NA
Q4 2020
2/25/2021
21.22-0.30-1.20NA
Q3 2020
11/4/2020
3.95-0.25-1.35NA
Q2 2020
8/7/2020
2.10-0.28-1.66NA
Q1 2020
5/7/2020
1.37-0.37-2.14NA
Q4 2019
2/25/2020
1.37-0.45-2.68NA
Q3 2019
11/7/2019
1.69-0.56-3.22NA
Q2 2019
8/8/2019
0.99-0.76-3.72NA
Q1 2019
5/8/2019
6.57-0.91-3.97NA
Q4 2018
3/18/2019
6.78-0.99-4.04NA
Q3 2018
11/6/2018
11.75-1.06-3.85NA
Q2 2018
8/3/2018
17.80-1.01-3.42NA
Q1 2018
5/8/2018
18.37-0.98-2.97NA
Q4 2017
3/12/2018
19.75-0.80-2.47NA
Q3 2017
11/7/2017
21.98-0.63-2.16NA
Q2 2017
8/8/2017
26.73-0.56-2.03NA
Q1 2017
5/9/2017
25.11-0.48-2.09NA
Q4 2016
3/15/2017
30.65-0.49-2.26NA
Q3 2016
11/3/2016
20.74-0.50-2.05NA
Q2 2016
8/11/2016
19.14-0.62-6.66NA
Q1 2016
5/11/2016
17.97-0.65NANA
Q4 2015
3/23/2016
15.00-0.28NANA
Q3 2015
11/18/2015
19.95-5.11NANA
ACRS Historical PE Ratio Chart
PeriodPriceGAAPAnnualizedPE
Q3 2022
11/8/2022
16.21-0.30-1.20NA
Q2 2022
8/3/2022
14.40-0.31-1.24NA
Q1 2022
5/10/2022
11.12-0.31-1.24NA
Q4 2021
2/24/2022
14.12-0.37-1.48NA
Q3 2021
11/2/2021
16.48-0.35-1.40NA
Q2 2021
8/5/2021
14.76-0.34-1.36NA
Q1 2021
5/7/2021
22.95-0.57-2.28NA
Q4 2020
2/25/2021
21.22-0.30-1.20NA
Q3 2020
11/4/2020
3.95-0.25-1.00NA
Q2 2020
8/7/2020
2.10-0.28-1.12NA
Q1 2020
5/7/2020
1.37-0.37-1.48NA
Q4 2019
2/25/2020
1.37-0.45-1.80NA
Q3 2019
11/7/2019
1.69-0.56-2.24NA
Q2 2019
8/8/2019
0.99-0.76-3.04NA
Q1 2019
5/8/2019
6.57-0.91-3.64NA
Q4 2018
3/18/2019
6.78-0.99-3.96NA
Q3 2018
11/6/2018
11.75-1.06-4.24NA
Q2 2018
8/3/2018
17.80-1.01-4.04NA
Q1 2018
5/8/2018
18.37-0.98-3.92NA
Q4 2017
3/12/2018
19.75-0.80-3.20NA
Q3 2017
11/7/2017
21.98-0.63-2.52NA
Q2 2017
8/8/2017
26.73-0.56-2.24NA
Q1 2017
5/9/2017
25.11-0.48-1.92NA
Q4 2016
3/15/2017
30.65-0.49-1.96NA
Q3 2016
11/3/2016
20.74-0.50-2.00NA
Q2 2016
8/11/2016
19.14-0.62-2.48NA
Q1 2016
5/11/2016
17.97-0.65-2.60NA
Q4 2015
3/23/2016
15.00-0.28-1.12NA
Q3 2015
11/18/2015
19.95-5.11-20.44NA
Quotes delayed 20 minutes

Email EnvelopeFree ACRS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Aclaris Therapeutics (ACRS) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

ACRX PE Ratio History
ACXP PE Ratio History
ADGI PE Ratio History
ADIL PE Ratio History
ADMA PE Ratio History
ADMP PE Ratio History
ADMS PE Ratio History
ADPT PE Ratio History
ADTX PE Ratio History
ADUS PE Ratio History
On this page we presented the ACRS PE Ratio History information for Aclaris Therapeutics' stock. The average ACRS PE ratio history based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is NA. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average ACRS PE ratio history based on this TTM earnings result method is NA. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this ACRS PE ratio history result, against the recent PE: when this page was posted on 11/9/2022, the most recent closing price for ACRS had been 16.21, and the most recent quarterly earnings result, annualized, was NA. Meanwhile, the most recent TTM earnings summed to NA.

For self directed investors doing their due diligence on ACRS or any other given stock, valuation analysis for ACRS can greatly benefit from studying the past earnings and resulting PE ratio history calculations. This type of study can help inform an analysis as to whether the earnings trajectory over time and current versus historical average PE ratios justify the current stock market value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Aclaris Therapeutics PE ratio history — or the PE history for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for next earnings dates and also historical earnings surprises history for ACRS. Thanks for visiting, and the next time you need to research ACRS PE Ratio History or the PE ratio history for another stock, we hope our site will come to mind as your go-to PE ratio history research resource of choice.

Recommended: META market cap history, Top Ten Hedge Funds Holding IMTB, Funds Holding LNCE.

 

ACRS PE Ratio History | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.